Hutchmed (China) LTD 6-K Filing
Ticker: HMDCF · Form: 6-K · Filed: Dec 29, 2025 · CIK: 1648257
Sentiment: neutral
Filing Stats: 183 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2025-12-29 06:07:55
Filing Documents
- hcm-20251229x6k.htm (6-K) — 22KB
- hcm-20251229xex99d1.htm (EX-99.1) — 37KB
- hcm-20251229xex99d2.htm (EX-99.2) — 21KB
- hcm-20251229xex99d1001.gif (GRAPHIC) — 4KB
- hcm-20251229xex99d2001.gif (GRAPHIC) — 4KB
- 0001648257-25-000087.txt ( ) — 92KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to b locklisting s ix m onthly r eturn Exhibit 99.2 Press release relating to NDA Acceptance in China with priority review status for fanregratinib in second-line intrahepatic cholangiocarcinoma 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 29, 2025 3